切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2024, Vol. 13 ›› Issue (01) : 72 -77. doi: 10.3877/cma.j.issn.2095-3232.2024.01.014

临床研究

胆管内乳头状黏液瘤三例诊治及文献复习
聂云贵, 肖广发()   
  1. 415000 湖南省常德市,湘雅常德医院普通外科
  • 收稿日期:2023-09-04 出版日期:2024-02-10
  • 通信作者: 肖广发
  • 基金资助:
    湖南省卫生健康委员会一般指导课题(202204015405)

Diagnosis and treatment of intraductal papillary mucinous neoplasm of the bile duct: report of three cases and literature review

Yungui Nie, Guangfa Xiao()   

  1. Department of General Surgery, Xiangya Changde Hospital, Changde 415000, China
  • Received:2023-09-04 Published:2024-02-10
  • Corresponding author: Guangfa Xiao
引用本文:

聂云贵, 肖广发. 胆管内乳头状黏液瘤三例诊治及文献复习[J]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 72-77.

Yungui Nie, Guangfa Xiao. Diagnosis and treatment of intraductal papillary mucinous neoplasm of the bile duct: report of three cases and literature review[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(01): 72-77.

目的

探讨胆管内乳头状黏液瘤(IPMN-B)临床病理特征及诊治要点。

方法

回顾性分析2017年12月至2020年1月湘雅常德医院收治的3例IPMN-B患者临床资料。患者均为女性,年龄分别为60、45、66岁。腹痛2例,黄疸1例,低热、纳差1例。TB升高2例,CA19-9升高1例。超声、CT、MRI检查示胆管扩张,胆管下端梗阻,胆管壁增厚。结合国内外文献总结IPMN-B的临床表现、病理特点、诊断、治疗及预后。

结果

3例IPMN-B在胆道镜下均表现为胆管内壁上绒毛状或鱼卵状新生物,均行手术切除治疗。例1术后病理学检查为IPMN-B并中分化腺癌,出院后8个月出现胸背部及腰腿疼,复查CA19-9 1 614 kU/L;出院后10个月复查脊柱及骨盆MRI提示胸骨、锥体、骨盆、股骨多发异常信号,考虑转移;PET-CT示胆肠吻合口代谢活跃、全身多发骨质破坏,代谢活跃,考虑肿瘤复发、术区及全身骨多发转移;予以FOLFOX4方案化疗8次;术后18个月死亡。其余2例患者随访期间无复发,无消化道相关症状。

结论

IPMN-B的临床表现与血生化检查指标不具有特异性,术前诊断主要以影像学为主,术中胆道镜准确判定病变范围,采取积极合理的手术治疗对IPMN-B的诊治十分重要。

Objective

To investigate clinicopathological features, diagnosis and treatment of intraductal papillary mucinous neoplasm of the bile tract (IPMN-B).

Methods

Clinical data of 3 patients with IPMN-B admitted to Xiangya Changde Hospital from December 2017 to January 2020 were retrospectively analyzed. All patients were female, aged 60, 45 and 66 years. 2 patients experienced abdominal pain, 1 case of jaundice, 1 case of low fever and anorexia. TB levels were increased in 2 cases and CA19-9 level was increased in 1 case. Ultrasound, CT scan and MRI showed bile duct dilatation, obstruction at the lower end of bile duct and thickening of bile duct wall. Clinical manifestations, pathological features, diagnosis, treatment and prognosis of IPMN-B were summarized according to literature review at home and abroad.

Results

All3 IPMN-B patients showed villous or fish-egg-like lesions on the inner wall of bile duct under choledochoscopy, and all of them were surgically removed. Case 1 was diagnosed with IPMN-B complicated with moderately-differentiated adenocarcinoma by postoperative pathological examination, and experienced chest, back, waist and leg pain at 8 months after discharge. CA19-9 level was detected as 1 614 kU/L. At 10 months after discharge, MRI of the spine and pelvis showed multiple abnormal signals in the sternum, vertebra, pelvis and femur. The possibility of metastasis was considered. PET-CT revealed active metabolism at biliary-intestinal anastomosis site, systemic bone destruction and active metabolism. The possibility of tumor recurrence and of surgical metastase site, systemic bone metastases was suspected. FOLFOX4 chemotherapy was given for 8 times. The patient died at 18 months after operation. No recurrence and digestive tract-related symptoms were reported in the other 2 cases during follow-up.

Conclusions

Clinical manifestations and biochemical detection indexes of IPMN-B are not specific. Preoperative diagnosis is mainly made based on imaging examination. Accurate delineation of lesion range by intraoperative choledochoscopy, and active and rational surgical interventions play a critical role in the diagnosis and treatment of IPMN-B.

表1 三例IPMN-B患者的一般资料
图1 例一IPMN-B患者围手术期检查注:a为术前T管造影示右肝内胆管及胆总管扩张,左肝管未见显影,胆总管内形态不规则充盈缺损影;b为CT示肝内胆管及胆总管明显扩张并积气;c为镜下示癌细胞呈腺腔样排列(HE ×200);IPMN-B为胆管内乳头状黏液瘤
图2 例二IPMN-B患者围手术期检查注:a为术前MRCP示肝内外胆管扩张,左肝外叶胆管内信号不均;b为胆道镜示左外叶胆管内充满云絮状黏液;c为切除标本示左外叶萎缩,剖开病变胆管见胆管明显扩张,内含胶冻状黏液;IPMN-B为胆管内乳头状黏液瘤
图3 例三IPMN-B患者围手术期检查注:a为MRCP示肝内外胆管全程扩张,未见实体肿瘤或胆总管末段狭窄征象;b为胆道镜示右肝胆管内壁上绒毛状新生组织;c为胆管内上皮乳头状增生,部分上皮呈中度异型增生(HE ×200);IPMN-B为胆管内乳头状黏液瘤
表2 三例IPMN-B患者的手术方式及预后
表3 胆道IPNB与胰腺IPMN-P病理组织结构的异同点[9]
项目 相似点 区别点
病变的大体与微观结构 (1)均为乳头状肿瘤性癌前病变;(2)在主要的乳头状肿瘤周边常存在扁平或少量乳头状上皮内瘤变 (1)IPMN-P表现为病变胰管的囊性或多囊性导管扩张,肝内型IPNB可有类似病变,而肝外型IPNB表现为圆柱状或梭形扩张;(2)IPNB在肿瘤体积和长度方面要大于或长于IPMN-P
4种亚型 均有胰胆型、小肠型、胃型和嗜酸型 IPNB和IPMN-P的亚型组织学形态并不完全一样
大量黏液分泌进入管腔 IPMN-P几乎均可见黏液分泌,肝内型IPNB常可见黏液分泌 肝外型IPNB大量分泌黏液的情况少见
乳头状病变的上皮内瘤变分级 均可表现低-中-高级别不典型增生 (1)大部分IPNB表现为高级别不典型增生;(2)MD-IPMN常为高级别不典型增生,BD-IPMN常为低-中级别不典型增生
复杂结构 有些IPNB在形态和结构上与IPMN-P有类似或几乎一样的乳头状或绒毛状结构 有些IPNB除了乳头状结构,可有局灶性实质肿块,呈筛状或管状生长
间质浸润 (1)均可进展为浸润性腺癌;(2)肝内型IPNB很少浸润性,肝外型IPNB常表现为浸润性。MD-IPMN常表现为浸润性,BD-IPMN少见浸润性 (1)IPMN-P的浸润性区域中,胶状癌常见,管状或嗜酸性癌并纤维化反应少见;(2)IPNB的浸润性区域中,几乎均可见管状腺癌并纤维化反应,偶尔可见胶状癌或嗜酸性癌
[1]
郭伟, 张忠涛. 胆管内乳头状肿瘤的诊断与治疗[J]. 中华消化外科杂志, 2018, 17(3):233-236.
[2]
Bosma FT, Cameiro F, Hruban RH, et al. WHO classification of tumours of the digestive system[M]. 4th ed. Lyon: International Agency for Research on Cancer, 2010.
[3]
Ohtsuka M, Kimura F, Shimizu H, et al. Similarities and differences between intraductal papillary tumor of the bile duct with and without macroscopically visible mucin secretion[J]. Am J Surg Pathol, 2011, 35(4):512-521.
[4]
Xu XW, Li RH, Zhou W, et al. Intraductal papillary neoplasm of the bile duct[J]. World J Gastroenterol, 2013, 19(46):8595-8604.
[5]
Yeh TS, Tseng JH, Chen TC, et al. Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions[J]. Hepatology 2005, 42(3):657-664.
[6]
Kim KM, Lee JK, Shin JU, et al. Clinicopathologic features of intraductal papillary neoplasm of the bile duct according to histologic subtype[J]. Am J Gastroenterol, 2012, 107(1):118-125.
[7]
王辛, 陈拥华, 蔡云强, 等. 胆管内与胰腺导管内乳头状黏液性肿瘤的比较[J]. 中华肝胆外科杂志, 2015, 21(9):620-624.
[8]
Nakanuma Y, Jang KT, Fukushima N, et al. A statement by the Japan-Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stage[J]. J Hepatobiliary Pancreat Sci, 2018, 25(3):181-187.
[9]
Nakanuma Y, Kakuda Y, Uesaka K. Characterization of intraductal papillary neoplasm of the bile duct with respect to the histopathologic similarities to pancreatic intraductal papillary mucinous neoplasm[J]. Gut Liver, 2019, 13(6):617-627.
[10]
Takanami K, Yamada T, Tsuda M, et al. Intraductal papillary mucininous neoplasm of the bile ducts: multimodality assessment with pathologic correlation[J]. Abdom Imaging, 2011, 36(4):447-456.
[11]
Tsuyuguchi T, Sakai Y, Sugiyama H, et al. Endoscopic diagnosis of intraductal papillary mucinous neoplasm of the bile duct[J]. J Hepatobiliary Pancreat Sci, 2010, 17(3):230-235.
[12]
Sakai YJ, Ohtsuka M, Sugiyama H, et al. Current status of diagnosis and therapy for intraductal papillary neoplasm of the bile duct[J]. World J Gastroenterol 2021, 27(15):1569-1577.
[13]
Anné F, Snauwaert C, Vandeputte L, et al. The added value of peroral cholangioscopy to diagnose intraductal papillary neoplasm of the bile duct[J]. Endoscopy, 2022, DOI:10.1055/a-1792-2395[Epub aheadof print].
[14]
Youn JM, Hwang S, Ahn CS, et al. Clinicopathological features and long-term outcomes of intraductal papillary neoplasms of the bile duct of the liver: single-institution experience with 146 patients[J]. J Gastrointest Surg, 2022, 26(7):1394-1405.
[15]
Gordon-Weeks AN, Jones K, Harriss E, et al. Systematic review and meta-analysis of current experience in treating IPNB: clinical and pathological correlates[J]. Ann Surg, 2016, 263(4):656-663.
[16]
陈聪颖, 张汝玲, 乔良, 等. 巨大胆管内乳头状黏液性肿瘤破裂致慢性胶冻样腹水1例报告[J]. 临床肝胆病杂志, 2023, 39(1):147-151.
[17]
Onoe S, Ebata T, Yokoyama Y, et al. A clinicopathological reappraisal of intraductal papillary neoplasm of the bile duct (IPNB): a continuous spectrum with papillary cholangiocarcinoma in 181 curatively resected cases[J]. HPB, 2021, 23(10):1525-1532.
[18]
Rocha FG, Lee H, Katabi N, et al. Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?[J]. Hepatology, 2012, 56(4):1352-1360.
[19]
Wu X, Li BL, Zheng CJ, et al. Intraductal papillary neoplasm of the bile duct:a single-center retrospective study[J]. J Int Med Res, 2018, 46(10):4258-4268.
[20]
Zhang YQ, Liang Y, Liu Y, et al. Photodynamic therapy for hepatic hilar intraductal papillary neoplasm of the bile duct: a case report[J]. VideoGIE, 2022, 7(5):178-181.
[21]
Matsumoto T, Kubota K, Hachiya H, et al. Impact of tumor location on postoperative outcome of intraductal papillary neoplasm of the bile duct[J]. World J Surg, 2019, 43(5):1313-1322.
[1] 郑泽坤, 刘卓恒, 邹浩, 胡会元, 李妲, 吴巍. 扩大根治性手术切除复发性巨大腹膜后去分化脂肪肉瘤1例[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 588-590.
[2] 范伟强, 林师佈, 孙传伟, 宋奇锋, 李望, 符誉, 陈艾. 不同切除范围的Bismuth-Corlette Ⅲ、Ⅳ型腹腔镜肝门部胆管癌手术临床对比分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 423-426.
[3] 宋铭杰, 韩青雷, 李佳隆, 邵英梅. 内镜下晚期肝外胆管恶性肿瘤消融治疗研究现况[J]. 中华普外科手术学杂志(电子版), 2023, 17(03): 340-342.
[4] 郑泽坤, 戴勇, 陈卓, 吴巍. 根治性手术切除罕见的巨大胃肠间质瘤一例[J]. 中华普外科手术学杂志(电子版), 2023, 17(02): 235-236.
[5] 潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强. 淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 608-612.
[6] 李斌奎. 不可切除肝内胆管细胞癌的转化治疗[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 511-516.
[7] 田驹, 孙伯洋, 杨荣华, 赵向前. 术中意外发现肝外胆管绒毛管状腺瘤的外科处理经验:附两例报道并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 567-571.
[8] 陈雪岩, 孟兴凯. 肝门空肠吻合术在肝门部胆管癌根治术中的应用价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 440-443.
[9] 周标, 陈达伟, 汤晓东, 陈胜, 刘双海, 邓志成. 腹腔镜下经胆囊管汇入部微切开取石在细径胆总管结石合并胆囊结石中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 422-426.
[10] 吴周宇, 周宝勇, 李明. 基于PSM分析腹腔镜肝门部胆管癌根治术安全性[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 384-388.
[11] 杨传鑫, 王伟, 王坚. 残余左肝管内乳头状黏液瘤一例报告[J]. 中华肝脏外科手术学电子杂志, 2023, 12(02): 236-238.
[12] 涂建华, 史亚波, 李杨, 刘华兵, 黄长文, 饶雪峰. 一期与二期经皮经肝胆道镜取石术治疗中国肝内胆管结石患者安全性与疗效比较Meta分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(02): 201-205.
[13] 莫建涛, 杨沛泽, 曹瑞奇, 马清涌, 王铮, 仵正, 周灿灿. 基于生物信息学分析构建肝内胆管细胞癌患者铁死亡相关lncRNA预后模型[J]. 中华肝脏外科手术学电子杂志, 2023, 12(02): 185-189.
[14] 张波, 姚怡, 张文刚, 柴宁莉, 令狐恩强. 胆道镜直视系统在胆胰"超级微创理念"中的诊疗价值[J]. 中华胃肠内镜电子杂志, 2023, 10(04): 264-266.
[15] 董浩, 张文刚, 刘圣圳, 李笑, 冯宇杰, 王佳凤, 赵晨怡, 柴宁莉, 令狐恩强. 胆道镜直视下胆总管结石取出术的初步探索[J]. 中华胃肠内镜电子杂志, 2023, 10(02): 92-96.
阅读次数
全文


摘要